1.
Thomas Hedner, Jean Lycke. CRISPR/Cas9 system and gene editing tools: On patent rights, recent disputes and its potential commercial applicability in biotechnology and medicine. SIPLR [Internet]. 2019 Jun. 1 [cited 2026 Oct. 29];2(1):12-23. Available from: https://publicera.kb.se/siplr/article/view/63298